ID 5HT1D_HUMAN Reviewed; 377 AA. AC P28221; DT 01-DEC-1992, integrated into UniProtKB/Swiss-Prot. DT 01-DEC-1992, sequence version 1. DT 02-SEP-2026, entry version 204. DE RecName: Full=5-hydroxytryptamine receptor 1D {ECO:0000303|PubMed:1652050}; DE Short=5-HT-1D {ECO:0000303|PubMed:1652050}; DE Short=5-HT1D {ECO:0000303|PubMed:1652050}; DE AltName: Full=Serotonin 1D alpha receptor {ECO:0000303|PubMed:1652050}; DE Short=5-HT-1D-alpha {ECO:0000303|PubMed:1652050}; DE AltName: Full=Serotonin receptor 1D {ECO:0000303|PubMed:1652050}; GN Name=HTR1D {ECO:0000312|HGNC:HGNC:5289}; Synonyms=HTR1DA, HTRL; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=1652050; DOI=10.1016/s0026-895x(25)12918-0; RA Hamblin M.W., Metcalf M.A.; RT "Primary structure and functional characterization of a human 5-HT1D-type RT serotonin receptor."; RL Mol. Pharmacol. 40:143-148(1991). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION. RC TISSUE=Placenta; RX PubMed=1565658; DOI=10.1073/pnas.89.8.3630; RA Weinshank R.L., Zgombick J.M., Macchi M.J., Branchek T.A., Hartig P.R.; RT "Human serotonin 1D receptor is encoded by a subfamily of two distinct RT genes: 5-HT1D alpha and 5-HT1D beta."; RL Proc. Natl. Acad. Sci. U.S.A. 89:3630-3634(1992). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Puhl H.L. III, Ikeda S.R., Aronstam R.S.; RT "cDNA clones of human proteins involved in signal transduction sequenced by RT the Guthrie cDNA resource center (www.cdna.org)."; RL Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., RA Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., RA Phelan M., Farmer A.; RT "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."; RL Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Eye; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP TISSUE SPECIFICITY. RX PubMed=1828434; DOI=10.1016/0014-4886(91)90142-y; RA Gonzalez-Heydrich J., Peroutka S.J.; RT "Postsynaptic localization of 5-HT1D receptor binding sites in human RT caudate."; RL Exp. Neurol. 113:28-30(1991). RN [8] RP FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION. RX PubMed=10452531; DOI=10.1016/s0014-5793(99)00918-7; RA Xie Z., Lee S.P., O'Dowd B.F., George S.R.; RT "Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone RT and heterodimers when co-expressed."; RL FEBS Lett. 456:63-67(1999). RN [9] RP REVIEW. RX PubMed=18476671; DOI=10.1021/cr078224o; RA Nichols D.E., Nichols C.D.; RT "Serotonin receptors."; RL Chem. Rev. 108:1614-1641(2008). RN [10] RP REVIEW. RX PubMed=20945968; DOI=10.33549/physiolres.931903; RA Pytliak M., Vargova V., Mechirova V., Felsoci M.; RT "Serotonin receptors - from molecular biology to clinical applications."; RL Physiol. Res. 60:15-25(2011). RN [11] {ECO:0007744|PDB:7E32} RP STRUCTURE BY ELECTRON MICROSCOPY (2.99 ANGSTROMS) OF 2-377 IN COMPLEX WITH RP SEROTONON; GNB1; GNG2 AND GNAI1, DISULFIDE BOND, AND FUNCTION. RX PubMed=33762731; DOI=10.1038/s41586-021-03376-8; RA Xu P., Huang S., Zhang H., Mao C., Zhou X.E., Cheng X., Simon I.A., RA Shen D.D., Yen H.Y., Robinson C.V., Harpsoee K., Svensson B., Guo J., RA Jiang H., Gloriam D.E., Melcher K., Jiang Y., Zhang Y., Xu H.E.; RT "Structural insights into the lipid and ligand regulation of serotonin RT receptors."; RL Nature 592:469-473(2021). RN [12] RP VARIANT LEU-265. RX PubMed=10391209; DOI=10.1038/10290; RA Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., RA Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., RA Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., RA Lander E.S.; RT "Characterization of single-nucleotide polymorphisms in coding regions of RT human genes."; RL Nat. Genet. 22:231-238(1999). RN [13] RP ERRATUM OF PUBMED:10391209. RA Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., RA Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., RA Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., RA Lander E.S.; RL Nat. Genet. 23:373-373(1999). CC -!- FUNCTION: G protein-coupled receptor for 5-hydroxytryptamine CC (serotonin) (PubMed:10452531, PubMed:1565658, PubMed:1652050, CC PubMed:33762731). Also functions as a receptor for ergot alkaloid CC derivatives, various anxiolytic and antidepressant drugs and other CC psychoactive substances (PubMed:10452531, PubMed:1565658, CC PubMed:1652050, PubMed:33762731). Ligand binding causes a conformation CC change that triggers signaling via guanine nucleotide-binding proteins CC (G proteins) and modulates the activity of downstream effectors, such CC as adenylate cyclase (PubMed:10452531, PubMed:1565658, PubMed:1652050, CC PubMed:33762731). HTR1D is coupled to G(i)/G(o) G alpha proteins and CC mediates inhibitory neurotransmission by inhibiting adenylate cyclase CC activity (PubMed:33762731). Regulates the release of 5- CC hydroxytryptamine in the brain, and thereby affects neural activity CC (PubMed:18476671, PubMed:20945968). May also play a role in regulating CC the release of other neurotransmitters (PubMed:18476671, CC PubMed:20945968). May play a role in vasoconstriction (PubMed:18476671, CC PubMed:20945968). {ECO:0000269|PubMed:10452531, CC ECO:0000269|PubMed:1565658, ECO:0000269|PubMed:1652050, CC ECO:0000269|PubMed:33762731, ECO:0000303|PubMed:18476671, CC ECO:0000303|PubMed:20945968}. CC -!- SUBUNIT: Homodimer. Heterodimer with HTR1B. CC {ECO:0000269|PubMed:10452531}. CC -!- INTERACTION: CC P28221; O60896: RAMP3; NbExp=2; IntAct=EBI-67111268, EBI-720447; CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10452531, CC ECO:0000269|PubMed:1565658, ECO:0000269|PubMed:1652050}; Multi-pass CC membrane protein {ECO:0000269|PubMed:10452531, CC ECO:0000269|PubMed:1565658, ECO:0000269|PubMed:1652050}. CC -!- TISSUE SPECIFICITY: Detected in brain neocortex and caudate nucleus (at CC protein level). {ECO:0000269|PubMed:1828434}. CC -!- SIMILARITY: Belongs to the G protein-coupled receptor 1 family. CC {ECO:0000255|PROSITE-ProRule:PRU00521}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M89955; AAA35491.1; -; Genomic_DNA. DR EMBL; M81589; AAA60315.1; -; mRNA. DR EMBL; AF498979; AAM21126.1; -; mRNA. DR EMBL; BT007027; AAP35673.1; -; mRNA. DR EMBL; AL049576; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC007720; AAH07720.1; -; mRNA. DR CCDS; CCDS231.1; -. DR PIR; A53279; A53279. DR RefSeq; NP_000855.1; NM_000864.5. DR PDB; 7E32; EM; 2.90 A; R=2-377. DR AlphaFoldDB; P28221; -. DR EMDB; EMD-30974; -. DR SMR; P28221; -. DR BioGRID; 109584; 3. DR CORUM; P28221; -. DR FunCoup; P28221; 920. DR IntAct; P28221; 3. DR NDEx; IQUERY-CP-HTR1D; 5 NDEx IQuery Curated Pathways. DR STRING; 9606.ENSP00000363748; -. DR BindingDB; P28221; -. DR ChEMBL; CHEMBL1983; -. DR DrugBank; DB01465; 2,5-Dimethoxyamphetamine. DR DrugBank; DB00918; Almotriptan. DR DrugBank; DB20494; Alniditan. DR DrugBank; DB00321; Amitriptyline. DR DrugBank; DB00714; Apomorphine. DR DrugBank; DB01238; Aripiprazole. DR DrugBank; DB14185; Aripiprazole lauroxil. DR DrugBank; DB20150; Avitriptan. DR DrugBank; DB01484; Brolamfetamine. DR DrugBank; DB01200; Bromocriptine. DR DrugBank; DB01445; Bufotenine. DR DrugBank; DB00248; Cabergoline. DR DrugBank; DB01239; Chlorprothixene. DR DrugBank; DB00363; Clozapine. DR DrugBank; DB11273; Dihydroergocornine. DR DrugBank; DB13345; Dihydroergocristine. DR DrugBank; DB00320; Dihydroergotamine. DR DrugBank; DB20163; Donitriptan. DR DrugBank; DB00216; Eletriptan. DR DrugBank; DB01049; Ergoloid mesylate. DR DrugBank; DB00696; Ergotamine. DR DrugBank; DB19706; Etisulergine. DR DrugBank; DB00574; Fenfluramine. DR DrugBank; DB00998; Frovatriptan. DR DrugBank; DB01221; Ketamine. DR DrugBank; DB12540; Lecozotan. DR DrugBank; DB00589; Lisuride. DR DrugBank; DB04948; Lofexidine. DR DrugBank; DB00408; Loxapine. DR DrugBank; DB12110; m-Chlorophenylpiperazine. DR DrugBank; DB13520; Metergoline. DR DrugBank; DB00952; Naratriptan. DR DrugBank; DB06096; NXN-188. DR DrugBank; DB00334; Olanzapine. DR DrugBank; DB00935; Oxymetazoline. DR DrugBank; DB01267; Paliperidone. DR DrugBank; DB01186; Pergolide. DR DrugBank; DB12288; Piromelatine. DR DrugBank; DB01224; Quetiapine. DR DrugBank; DB19963; Quipazine. DR DrugBank; DB00734; Risperidone. DR DrugBank; DB00953; Rizatriptan. DR DrugBank; DB08839; Serotonin. DR DrugBank; DB09304; Setiptiline. DR DrugBank; DB00669; Sumatriptan. DR DrugBank; DB13025; Tiapride. DR DrugBank; DB20677; Tidembersat. DR DrugBank; DB06578; Tonabersat. DR DrugBank; DB00726; Trimipramine. DR DrugBank; DB01392; Yohimbine. DR DrugBank; DB00246; Ziprasidone. DR DrugBank; DB00315; Zolmitriptan. DR DrugCentral; P28221; -. DR GuidetoPHARMACOLOGY; 3; -. DR GlyCosmos; P28221; 3 sites, No reported glycans. DR GlyGen; P28221; 3 sites. DR iPTMnet; P28221; -. DR PhosphoSitePlus; P28221; -. DR BioMuta; HTR1D; -. DR DMDM; 112819; -. DR PaxDb; 9606-ENSP00000363748; -. DR Antibodypedia; 15559; 228 antibodies from 31 providers. DR DNASU; 3352; -. DR Ensembl; ENST00000374619.2; ENSP00000363748.1; ENSG00000179546.6. DR Ensembl; ENST00000918575.1; ENSP00000588634.1; ENSG00000179546.6. DR Ensembl; ENST00000918576.1; ENSP00000588635.1; ENSG00000179546.6. DR Ensembl; ENST00000918577.1; ENSP00000588636.1; ENSG00000179546.6. DR Ensembl; ENST00000918578.1; ENSP00000588637.1; ENSG00000179546.6. DR Ensembl; ENST00000918579.1; ENSP00000588638.1; ENSG00000179546.6. DR Ensembl; ENST00000918580.1; ENSP00000588639.1; ENSG00000179546.6. DR Ensembl; ENST00000918581.1; ENSP00000588640.1; ENSG00000179546.6. DR Ensembl; ENST00000918582.1; ENSP00000588641.1; ENSG00000179546.6. DR Ensembl; ENST00000918583.1; ENSP00000588642.1; ENSG00000179546.6. DR Ensembl; ENST00000918584.1; ENSP00000588643.1; ENSG00000179546.6. DR Ensembl; ENST00000918585.1; ENSP00000588644.1; ENSG00000179546.6. DR Ensembl; ENST00000918586.1; ENSP00000588645.1; ENSG00000179546.6. DR GeneID; 3352; -. DR KEGG; hsa:3352; -. DR MANE-Select; ENST00000374619.2; ENSP00000363748.1; NM_000864.5; NP_000855.1. DR UCSC; uc001bgn.3; human. DR AGR; HGNC:5289; -. DR ClinPGx; PA29550; -. DR CTD; 3352; -. DR DisGeNET; 3352; -. DR GeneCards; HTR1D; -. DR HGNC; HGNC:5289; HTR1D. DR HPA; ENSG00000179546; Group enriched (brain, intestine). DR MIM; 182133; gene. DR OpenTargets; ENSG00000179546; -. DR VEuPathDB; HostDB:ENSG00000179546; -. DR eggNOG; KOG3656; Eukaryota. DR GeneTree; ENSGT00940000154484; -. DR HOGENOM; CLU_009579_11_1_1; -. DR InParanoid; P28221; -. DR OMA; VWMISIS; -. DR OrthoDB; 5956310at2759; -. DR PAN-GO; P28221; 7 GO annotations based on evolutionary models. DR PhylomeDB; P28221; -. DR PathwayCommons; P28221; -. DR Reactome; R-HSA-390666; Serotonin receptors. DR Reactome; R-HSA-418594; G alpha (i) signalling events. DR SignaLink; P28221; -. DR SIGNOR; P28221; -. DR Agora; ENSG00000179546; -. DR BioGRID-ORCS; 3352; 8 hits in 1156 CRISPR screens. DR GeneWiki; 5-HT1D_receptor; -. DR GenomeRNAi; 3352; -. DR Pharos; P28221; Tclin. DR PRO; PR:P28221; -. DR Proteomes; UP000005640; Chromosome 1. DR RNAct; P28221; protein. DR Bgee; ENSG00000179546; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 57 other cell types or tissues. DR GO; GO:0030425; C:dendrite; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0045202; C:synapse; IEA:GOC. DR GO; GO:0004993; F:G protein-coupled serotonin receptor activity; IMP:UniProtKB. DR GO; GO:0001586; F:Gi/o-coupled serotonin receptor activity; IDA:UniProtKB. DR GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central. DR GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; IMP:UniProtKB. DR GO; GO:0007198; P:adenylate cyclase-inhibiting serotonin receptor signaling pathway; IDA:UniProtKB. DR GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central. DR GO; GO:0007187; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; IBA:GO_Central. DR GO; GO:0014827; P:intestine smooth muscle contraction; IMP:UniProtKB. DR GO; GO:0050795; P:regulation of behavior; IEA:InterPro. DR GO; GO:0040012; P:regulation of locomotion; IEA:InterPro. DR GO; GO:0042310; P:vasoconstriction; IEA:InterPro. DR CDD; cd15333; 7tmA_5-HT1B_1D; 1. DR Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1. DR InterPro; IPR000505; 5HT1D_rcpt. DR InterPro; IPR002231; 5HT_rcpt. DR InterPro; IPR000276; GPCR_Rhodpsn. DR InterPro; IPR017452; GPCR_Rhodpsn_7TM. DR PANTHER; PTHR24248:SF196; 5-HYDROXYTRYPTAMINE RECEPTOR 1D; 1. DR PANTHER; PTHR24248; ADRENERGIC RECEPTOR-RELATED G-PROTEIN COUPLED RECEPTOR; 1. DR Pfam; PF00001; 7tm_1; 1. DR PRINTS; PR00514; 5HT1DRECEPTR. DR PRINTS; PR01101; 5HTRECEPTOR. DR PRINTS; PR00237; GPCRRHODOPSN. DR SMART; SM01381; 7TM_GPCR_Srsx; 1. DR SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1. DR PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1. DR PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1. DR PDBsum; 7E32; -. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; Disulfide bond; G protein-coupled receptor; KW Glycoprotein; Membrane; Receptor; Reference proteome; Transducer; KW Transmembrane; Transmembrane helix. FT CHAIN 1..377 FT /note="5-hydroxytryptamine receptor 1D" FT /id="PRO_0000068927" FT TOPO_DOM 1..38 FT /note="Extracellular" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT TRANSMEM 39..64 FT /note="Helical; Name=1" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT TOPO_DOM 65..75 FT /note="Cytoplasmic" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT TRANSMEM 76..97 FT /note="Helical; Name=2" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT TOPO_DOM 98..109 FT /note="Extracellular" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT TRANSMEM 110..134 FT /note="Helical; Name=3" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT TOPO_DOM 135..154 FT /note="Cytoplasmic" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT TRANSMEM 155..176 FT /note="Helical; Name=4" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT TOPO_DOM 177..194 FT /note="Extracellular" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT TRANSMEM 195..218 FT /note="Helical; Name=5" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT TOPO_DOM 219..300 FT /note="Cytoplasmic" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT TRANSMEM 301..326 FT /note="Helical; Name=6" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT TOPO_DOM 327..335 FT /note="Extracellular" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT TRANSMEM 336..359 FT /note="Helical; Name=7" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT TOPO_DOM 360..377 FT /note="Cytoplasmic" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT REGION 1..23 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 135..137 FT /note="DRY motif; important for ligand-induced conformation FT changes" FT /evidence="ECO:0000250|UniProtKB:P41595" FT MOTIF 352..356 FT /note="NPxxY motif; important for ligand-induced FT conformation changes and signaling" FT /evidence="ECO:0000250|UniProtKB:P41595" FT BINDING 118 FT /ligand="serotonin" FT /ligand_id="ChEBI:CHEBI:350546" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT BINDING 122 FT /ligand="serotonin" FT /ligand_id="ChEBI:CHEBI:350546" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT BINDING 321 FT /ligand="serotonin" FT /ligand_id="ChEBI:CHEBI:350546" FT /evidence="ECO:0000269|PubMed:33762731, FT ECO:0007744|PDB:7E32" FT CARBOHYD 5 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 17 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 21 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 111..188 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00521, FT ECO:0000269|PubMed:33762731, ECO:0007744|PDB:7E32" FT VARIANT 265 FT /note="S -> L (in dbSNP:rs6299)" FT /evidence="ECO:0000269|PubMed:10391209" FT /id="VAR_011834" FT HELIX 36..65 FT /evidence="ECO:0007829|PDB:7E32" FT HELIX 67..69 FT /evidence="ECO:0007829|PDB:7E32" FT HELIX 72..86 FT /evidence="ECO:0007829|PDB:7E32" FT HELIX 87..91 FT /evidence="ECO:0007829|PDB:7E32" FT HELIX 92..101 FT /evidence="ECO:0007829|PDB:7E32" FT HELIX 107..141 FT /evidence="ECO:0007829|PDB:7E32" FT HELIX 143..149 FT /evidence="ECO:0007829|PDB:7E32" FT HELIX 152..170 FT /evidence="ECO:0007829|PDB:7E32" FT HELIX 172..176 FT /evidence="ECO:0007829|PDB:7E32" FT HELIX 195..202 FT /evidence="ECO:0007829|PDB:7E32" FT HELIX 203..207 FT /evidence="ECO:0007829|PDB:7E32" FT HELIX 208..229 FT /evidence="ECO:0007829|PDB:7E32" FT HELIX 285..326 FT /evidence="ECO:0007829|PDB:7E32" FT STRAND 328..330 FT /evidence="ECO:0007829|PDB:7E32" FT HELIX 335..358 FT /evidence="ECO:0007829|PDB:7E32" FT HELIX 361..370 FT /evidence="ECO:0007829|PDB:7E32" SQ SEQUENCE 377 AA; 41907 MW; 0A4FCF81FFE2322A CRC64; MSPLNQSAEG LPQEASNRSL NATETSEAWD PRTLQALKIS LAVVLSVITL ATVLSNAFVL TTILLTRKLH TPANYLIGSL ATTDLLVSIL VMPISIAYTI THTWNFGQIL CDIWLSSDIT CCTASILHLC VIALDRYWAI TDALEYSKRR TAGHAATMIA IVWAISICIS IPPLFWRQAK AQEEMSDCLV NTSQISYTIY STCGAFYIPS VLLIILYGRI YRAARNRILN PPSLYGKRFT TAHLITGSAG SSLCSLNSSL HEGHSHSAGS PLFFNHVKIK LADSALERKR ISAARERKAT KILGIILGAF IICWLPFFVV SLVLPICRDS CWIHPALFDF FTWLGYLNSL INPIIYTVFN EEFRQAFQKI VPFRKAS //